Abstract
Allergenic emulsions appear to be as effective as conventional aqueous therapy for treating allergic respiratory disease in properly selected patients.
Rigorous pretreatment screening of candidates for repository therapy is essential to avoid treatment failures and prevent the induction of skin reactivity to the antigens which are used.
The incidence of adverse local and systemic reactions which can occur following repository therapy can be minimized by careful preparation and testing of emulsions.